Profile data is unavailable for this security.
About the company
Malin Corporation PLC is focused on investing in life sciences companies. The Company’s assets give investors access to life sciences businesses with exposure across diverse modalities, therapeutic areas and geographies. Its business includes Poseida, Viamet, Xenex, CG Oncology, Wren, KNOW Bio and Artizan. Poseida is a clinical-stage biopharmaceutical company building a pipeline of Chimeric antigen receptor T cell (CAR-T) product candidates, initially focused on the treatment of hematological malignancies, including multiple myeloma, and solid tumours, like prostate cancer. It is also developing two CAR-T therapies: autologous and allogeneic. Xenex is a commercial-stage medical device company focused on reducing healthcare-associated infections with its non-mercury, full-spectrum disinfection LightStrike Germ-Zapping robots. CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder-saving therapeutics for patients with bladder cancer.
- Revenue in EUR (TTM)0.00
- Net income in EUR0.00
- Incorporated2014
- Employees3.00
- LocationMalin Corporation PLCThe Lennox Building50 Richmond Street SouthDUBLIN D02 FK02IrelandIRL
- Phone+353 19015700
- Fax+353 19015701
- Websitehttp://malinplc.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Haemato AG | 260.81m | 9.61m | 96.83m | 78.00 | 10.04 | 0.6452 | 8.99 | 0.3713 | 1.84 | 1.84 | 50.10 | 28.67 | 1.47 | 9.80 | 12.48 | 3,343,690.00 | 5.41 | 2.01 | 6.45 | 2.70 | 7.56 | 8.42 | 3.68 | 1.21 | 1.66 | -- | 0.0203 | 157.20 | -12.95 | -3.03 | 25.39 | 3.32 | -5.75 | -16.74 |
| Eco Animal Health Group Plc | 104.19m | -1.91m | 103.73m | 228.00 | -- | 1.08 | 36.54 | 0.9956 | -0.024 | -0.024 | 1.31 | 1.20 | 0.7664 | 1.92 | 3.41 | 387,986.80 | -0.1949 | 6.03 | -0.2645 | 8.02 | 43.05 | 46.41 | -0.2544 | 7.89 | 2.26 | 1.22 | 0.0437 | 55.72 | 3.79 | 4.89 | 246.94 | -35.90 | -4.43 | -- |
| Diamyd Medical AB | 24.77k | -10.55m | 105.61m | 26.00 | -- | 6.51 | -- | 4,264.52 | -1.41 | -1.41 | 0.0033 | 1.91 | 0.0014 | -- | 6.56 | 11,280.00 | -59.77 | -25.46 | -66.19 | -28.37 | -4,930.85 | -1,419.23 | -42,617.73 | -5,896.43 | -- | -130.78 | 0.1176 | -- | 20.26 | -5.54 | -12.13 | -- | -- | -- |
| SyntheticMR AB (publ) | 7.98m | 1.38m | 106.17m | 38.00 | 76.23 | 10.06 | 54.70 | 13.31 | 0.3804 | 0.3804 | 2.21 | 2.88 | 0.6719 | -- | 1.58 | 2,455,541.00 | 11.59 | 7.19 | 13.87 | 8.85 | 73.94 | 69.70 | 17.25 | 9.08 | -- | -- | 0.0083 | 21.50 | 30.67 | 13.05 | 70.34 | -7.33 | 27.30 | -- |
| Malin Corporation plc | 0.00 | 0.00 | 106.25m | 3.00 | -- | 0.9789 | 531.26 | -- | -0.0154 | -0.0154 | 0.00 | 5.77 | 0.00 | -- | -- | 0.00 | 0.00 | 7.09 | 0.00 | 7.66 | -- | -- | -- | 273.93 | -- | -- | 0.00 | 0.00 | -- | -- | -100.00 | -- | -- | -- |
| Scancell Holdings Plc | 0.00 | -13.33m | 106.56m | 51.00 | -- | -- | -- | -- | -0.0138 | -0.0138 | 0.00 | -0.0102 | 0.00 | -- | -- | 0.00 | -37.31 | -33.32 | -40.52 | -35.82 | -- | -- | -- | -817.98 | -- | -- | 1.73 | -- | -- | -- | -161.24 | -- | 77.85 | -- |
| Cereno Scientific AB | 0.00 | -5.19m | 108.57m | 5.00 | -- | 5.12 | -- | -- | -0.281 | -0.281 | 0.00 | 0.8598 | 0.00 | -- | -- | 0.00 | -24.71 | -16.81 | -26.65 | -18.26 | -- | -- | -- | -- | -- | -10.70 | 0.1843 | -- | -- | -- | -73.95 | -- | 44.79 | -- |
| Maat Pharma SA | 2.23m | -19.72m | 109.79m | 50.00 | -- | 4.48 | -- | 49.28 | -1.73 | -1.73 | 0.196 | 1.76 | 0.0508 | 4.84 | 4.16 | 44,560.00 | -44.99 | -35.49 | -58.93 | -42.98 | 74.28 | -- | -884.96 | -1,157.54 | 2.76 | -49.61 | 0.4075 | -- | 55.80 | -- | -43.78 | -- | 30.30 | -- |
| Scope Fluidics SA | 21.56k | -5.24m | 110.59m | 40.00 | -- | 6.44 | -- | 5,129.44 | -8.29 | -8.29 | 0.0341 | 27.18 | 0.0009 | 2.94 | 0.0337 | 2,325.00 | -21.76 | 52.74 | -22.74 | 57.32 | -2,022.58 | -420.87 | -24,304.30 | 30,134.78 | 13.86 | -- | 0.0299 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
| DBV Technologies SA | 14.47m | -66.90m | 111.26m | 104.00 | -- | 0.8591 | -- | 7.69 | -0.7051 | -0.7051 | 0.1521 | 1.34 | 0.0732 | -- | 1.18 | 139,152.00 | -33.86 | -53.18 | -40.10 | -65.47 | -- | 93.62 | -462.30 | -1,145.92 | -- | -- | 0.0388 | -- | 224.69 | -1.71 | 24.27 | -- | -34.47 | -- |
| Arcticzymes Technologies ASA | 10.19m | 1.52m | 112.00m | 68.00 | 73.91 | 4.13 | 54.30 | 11.00 | 0.3443 | 0.3443 | 2.30 | 6.17 | 0.3562 | 0.4228 | 6.29 | 1,731,471.00 | 5.31 | 15.58 | 5.66 | 17.22 | 95.50 | 96.69 | 14.91 | 33.23 | 12.14 | -- | 0.0327 | 0.00 | -13.16 | 12.24 | -40.89 | -- | 47.93 | -- |
| Medica SpA | 63.83m | 3.26m | 113.18m | 706.00 | 34.68 | 2.29 | 11.66 | 1.77 | 0.7727 | 0.7727 | 15.11 | 11.68 | 0.5817 | 1.07 | 5.22 | 90,672.33 | 2.26 | -- | 3.31 | -- | 58.28 | -- | 3.88 | -- | 0.8276 | 4.21 | 0.3487 | -- | 16.13 | -- | -12.52 | -- | -- | -- |
| Infant Bacterial Therapeutics AB | 0.00 | -11.28m | 115.47m | 9.00 | -- | 4.91 | -- | -- | -9.96 | -9.96 | 0.00 | 20.59 | 0.00 | -- | -- | 0.00 | -37.63 | -16.11 | -43.78 | -16.69 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -88.03 | -- | -- | -- |
| Eurofins-Cerep SA | 46.17m | 9.21m | 120.05m | 233.00 | 13.03 | 1.99 | 10.72 | 2.60 | 1,826.41 | 1,826.41 | 9,160.00 | 11,939.29 | 0.6814 | 1.66 | 6.04 | 220,892.00 | 13.60 | 15.19 | 16.06 | 18.94 | 85.57 | 67.30 | 19.95 | 19.72 | 5.17 | 112.42 | 0.00005 | 0.00 | 14.45 | 14.30 | 17.09 | 24.52 | -- | -- |
| Adocia SA | 2.15m | -21.16m | 123.83m | 78.00 | -- | -- | -- | 57.59 | -1.93 | -1.93 | 0.194 | -0.4908 | 0.0774 | 2.62 | 7.44 | 27,564.10 | -76.16 | -43.08 | -396.14 | -72.93 | 7.91 | -- | -984.28 | -514.53 | 1.01 | -2.07 | 2.12 | -- | -81.22 | -46.13 | -206.65 | -- | -27.60 | -- |
| Turk Ilac Ve Serum Sanayi AS | 54.81m | 3.03m | 124.68m | 439.00 | 41.17 | 3.54 | 31.47 | 2.27 | 0.6534 | 0.6534 | 11.82 | 7.60 | 1.28 | 32.39 | 3.39 | 4,358,227.00 | 7.07 | 3.18 | 11.06 | 5.52 | 22.43 | 23.44 | 5.53 | 2.36 | 1.20 | 1.67 | 0.25 | 0.00 | 16.88 | 81.44 | 229.47 | 49.00 | 37.65 | -- |
Data as of Jun 06 2024. Currency figures normalised to Malin Corporation PLC's reporting currency: Euro EUR
